You are here:
hydrocortisone (Plenadren)
Advice
In the absence of a submission from the holder of the marketing authorisation:
hydrocortisone (Plenadren®) is not recommended for use within NHS Scotland.
Indication under review: Treatment of adrenal insufficiency in adults.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
Drug Details
| Drug Name: | hydrocortisone (Plenadren) |
|---|---|
| SMC Drug ID: | 848/12 |
| Manufacturer: | ViroPharma Ltd |
| Indication: | Treatment of adrenal insufficiency in adults. |
| BNF Category: | |
| Sub Category: | 6.3 Corticosteroids |
| Submission Type: | Non submission |
| Status: | Not Recommended |
| Date Advice Published: | 14 January 2013 |